Maria Monica Gramatges, MD, PhD
- Cancer and Blood Disorders
Associate Section Chief, Oncology
Research Co-Director, Long-Term Survivor Program, Cancer and Hematology Center
Chair, Practice Standards Committee, Cancer and Hematology Center
Professor, Department of Pediatrics, Section of Hematology/Oncology, Baylor College of Medicine
Email: mmgramat@texaschildrens.org
Phone:
832-824-4678
Fax:
832-825-4651
Languages: English, Spanish
Office locations:
1102 Bates Avenue
Houston, TX 77030
Get to know Maria Monica Gramatges, MD, PhD
Dr. Maria Monica Gramatges is the Associate Section Chief of Oncology and Research Co-Director of the Long-Term Survivor Program at Texas Children’s Cancer and Hematology Center.
Within her role in the Long-Term Survivor Program, she develops and facilitates local and national collaborative research that investigates the physical, medical, and psychosocial late effects of treatment for childhood cancer.
Dr. Gramatges serves as Chair of the Texas Children’s Cancer and Hematology Center Practice Standards Committee. The objective of this committee is to develop and establish standards of practice that are based on the available evidence for the non-research related treatment of hematological/oncological diseases, as well as for related supportive care efforts.
Her clinical interests include both leukemia and cancer survivorship.
Education
| School | Education | Degree | Year |
|---|---|---|---|
| Baylor Graduate School of Biomedical Sciences | PhD | Doctor of Philosophy, Clinical Investigation | 2015 |
| Stanford University School of Medicine | Fellowship | Pediatric Hematology Oncology | 2009 |
| Oregon Health Sciences University | Residency | Pediatrics | 2006 |
| University of Texas at Houston | Medical School | Doctor of Medicine | 2003 |
| College of William and Mary | Bachelors | Bachelor of Science, Art History | 1998 |
Organizations
| Organization Name | Role |
|---|---|
| American Society for Clinical Investigation (ASCI) | Member |
| American Society for Pediatric Hematology/Oncology (ASPHO) | Member |
| American Society of Hematology (ASH) | Member |
| Children's Oncology Group (COG) | Member |
| Children's Oncology Group (COG) | Vice-Chair, Outcomes/Late Effects Committee |
| International Society of Paediatric Oncology (SIOP) | Member |
Board Certification
American Board of Pediatrics - Hematology/Oncology
Awards
2021 Northwestern Mutual Award for Excellence in Childhood Cancer Survivorship, American Society of
Pediatric Hematology/Oncology (ASPHO)
2018 Hyundai Hope on Wheels Scholar of Hope
2018 Golfer’s Against Cancer Award
2017 Faculty Recognition Award for Excellence in Teaching, Texas Children's Cancer and Hematology Center
2015 Fulbright and Jaworski Faculty Excellence Award in Teaching and Evaluation, Baylor College of Medicine
2014 John R. Kelsey, Jr. Student Speaker Award, Baylor College of Medicine Graduate School Symposium
2014 Scholar of Excellence Award, Texas Children's Cancer and Hematology Centers
2013 Mentored Research Scholar Grant, St. Baldrick’s Foundation
2012 Career Development Award, National Institutes of Health (NIH)
2012 Sponsor Summit Equipment Grant, Alex’s Lemonade Stand
2012 Chao Physician Scientist Award, Baylor College of Medicine
2011 Young Investigator Award, Alex’s Lemonade Stand
2010 American Society of Hematology (ASH) Clinical Research Training Institute
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Highlights
Key Health Outcomes of Long-Term Cancer Survivorship
Bringing Leukemia Research to the Bedside: Texas Children...
Research Area:
Epidemiology (Cancer and Hematology)
Genetics and Genomics
Leukemia
The objectives of the Gramatges lab are to uncover genetic risks, such as underlying defects in telomere maintenance, that may predispose children to cancer and cancer therapy-related toxicities as well as late effects. Her research explores these associations using human samples obtained locally and in collaboration with organizations such as the Children’s Oncology Group and the Childhood Cancer Survivor Study. Of particular interest to her lab are biomarkers of aging and frailty, and how these biological factors are related to features of premature, accelerated aging observed in survivors of childhood cancer.